These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38775415)

  • 1. Cutting Edge: LAG3 Dimerization Is Required for TCR/CD3 Interaction and Inhibition of Antitumor Immunity.
    Adam K; Lipatova Z; Abdul Ghafoor Raja M; Mishra AK; Mariuzza RA; Workman CJ; Vignali DAA
    J Immunol; 2024 Jul; 213(1):7-13. PubMed ID: 38775415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAG3 associates with TCR-CD3 complexes and suppresses signaling by driving co-receptor-Lck dissociation.
    Guy C; Mitrea DM; Chou PC; Temirov J; Vignali KM; Liu X; Zhang H; Kriwacki R; Bruchez MP; Watkins SC; Workman CJ; Vignali DAA
    Nat Immunol; 2022 May; 23(5):757-767. PubMed ID: 35437325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune checkpoint receptor LAG3: Structure, function, and target for cancer immunotherapy.
    Mariuzza RA; Shahid S; Karade SS
    J Biol Chem; 2024 May; 300(5):107241. PubMed ID: 38556085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia.
    Shapiro M; Herishanu Y; Katz BZ; Dezorella N; Sun C; Kay S; Polliack A; Avivi I; Wiestner A; Perry C
    Haematologica; 2017 May; 102(5):874-882. PubMed ID: 28154084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model.
    Huang RY; Eppolito C; Lele S; Shrikant P; Matsuzaki J; Odunsi K
    Oncotarget; 2015 Sep; 6(29):27359-77. PubMed ID: 26318293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective activation of antigen-experienced T cells by anti-CD3 constrained on nanoparticles.
    Lo YC; Edidin MA; Powell JD
    J Immunol; 2013 Nov; 191(10):5107-14. PubMed ID: 24098054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD3 delta establishes a functional link between the T cell receptor and CD8.
    Doucey MA; Goffin L; Naeher D; Michielin O; Baumgärtner P; Guillaume P; Palmer E; Luescher IF
    J Biol Chem; 2003 Jan; 278(5):3257-64. PubMed ID: 12215456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8
    Kim HD; Song GW; Park S; Jung MK; Kim MH; Kang HJ; Yoo C; Yi K; Kim KH; Eo S; Moon DB; Hong SM; Ju YS; Shin EC; Hwang S; Park SH
    Gastroenterology; 2018 Dec; 155(6):1936-1950.e17. PubMed ID: 30145359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for mouse LAG3 interactions with the MHC class II molecule I-A
    Ming Q; Antfolk D; Price DA; Manturova A; Medina E; Singh S; Mason C; Tran TH; Smalley KSM; Leung DW; Luca VC
    Nat Commun; 2024 Aug; 15(1):7513. PubMed ID: 39209860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ligand-dependent suppression of TCR signaling by the immune checkpoint receptor LAG3 depends on the cytoplasmic RRFSALE motif.
    Aigner-Radakovics K; De Sousa Linhares A; Salzer B; Lehner M; Izadi S; Castilho A; Pickl WF; Leitner J; Steinberger P
    Sci Signal; 2023 Oct; 16(805):eadg2610. PubMed ID: 37788323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoliposomes bearing lymphocyte activation gene 3 fusion protein and P5 peptide: A novel vaccine for breast cancer.
    Mohammadian Haftcheshmeh S; Zamani P; Mashreghi M; Nikpoor AR; Tavakkol-Afshari J; Jaafari MR
    Biotechnol Prog; 2021 Mar; 37(2):e3095. PubMed ID: 33118322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.
    Hannier S; Triebel F
    Int Immunol; 1999 Nov; 11(11):1745-52. PubMed ID: 10545478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70.
    Chen Z; Chen L; Qiao SW; Nagaishi T; Blumberg RS
    J Immunol; 2008 May; 180(9):6085-93. PubMed ID: 18424730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling.
    Hannier S; Tournier M; Bismuth G; Triebel F
    J Immunol; 1998 Oct; 161(8):4058-65. PubMed ID: 9780176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell receptor gene therapy of established tumors in a murine melanoma model.
    Abad JD; Wrzensinski C; Overwijk W; De Witte MA; Jorritsma A; Hsu C; Gattinoni L; Cohen CJ; Paulos CM; Palmer DC; Haanen JB; Schumacher TN; Rosenberg SA; Restifo NP; Morgan RA
    J Immunother; 2008 Jan; 31(1):1-6. PubMed ID: 18157006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.
    de Vries JE; Yssel H; Spits H
    Immunol Rev; 1989 Jun; 109():119-41. PubMed ID: 2527803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex.
    Thome M; Duplay P; Guttinger M; Acuto O
    J Exp Med; 1995 Jun; 181(6):1997-2006. PubMed ID: 7539035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts.
    Yashiro-Ohtani Y; Zhou XY; Toyo-Oka K; Tai XG; Park CS; Hamaoka T; Abe R; Miyake K; Fujiwara H
    J Immunol; 2000 Feb; 164(3):1251-9. PubMed ID: 10640738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.